Related Experiment Video

Updated: Aug 17, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Palliation of heart failure

Mellar P Davis1, Nancy M Albert, James B Young

  • 1The Harry R Horvitz Center for Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.

The American Journal of Hospice & Palliative Care
|May 25, 2005
PubMed

Insights

Stage D heart failure significantly impacts morbidity and mortality, often exceeding that of many cancers. Palliative care and cardiology collaboration are essential for managing these severe heart failure symptoms.

Area of Science:

  • Cardiology
  • Palliative Care
  • Heart Failure Pathophysiology

Background:

  • Heart failure is a leading cause of death and illness in the US.
  • Stage D heart failure presents severe symptoms and high mortality rates, comparable to advanced cancers.
  • Understanding heart failure pathophysiology has evolved, revealing links to ventricular remodeling and neurohumoral responses.

Purpose of the Study:

  • To highlight the critical need for palliative care in advanced heart failure (Stage D).
  • To emphasize the importance of interdisciplinary collaboration between cardiology and palliative care specialists.
  • To underscore the necessity of palliative strategies for highly symptomatic Stage D heart failure patients.

Main Methods:

  • Review of current understanding of Stage D heart failure pathophysiology.
  • Analysis of evolving drug classes targeting ventricular remodeling and neurohumoral responses.
  • Discussion on the role of palliative care in conjunction with existing therapies.

Main Results:

  • Despite advancements in drug and device therapies, Stage D heart failure management still requires palliative interventions.
  • Collaboration between cardiology and palliative care specialists can improve symptom management.
  • Interdisciplinary approaches form the foundation for effective research in advanced heart failure.

Conclusions:

  • Stage D heart failure demands integrated palliative care strategies.
  • Enhanced collaboration between cardiology and palliative care is crucial for improving patient outcomes.
  • Further research is needed to optimize palliative care in advanced heart failure.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...